Pharmaceutical Technology

MAY 9, 2023

Health Canada has approved Rhythm Pharmaceuticals’ IMCIVREE setmelanotide subcutaneous injection for use in weight management in adult and paediatric patients aged six years and above with Bardet-Biedl syndrome (BBS).

Genetics 130

Genetics Trials Medicine Drugs 130

XTalks

MARCH 12, 2024

The expanded approval makes Wegovy the first weight loss drug to also be approved for the prevention of cardiovascular events in adults with heart disease and either obesity or overweight. Wegovy is used in conjunction with dietary modifications and physical activity to help individuals lose weight.

Drugs 105

Drugs Production Trials Clinical Trials 105

STAT News

AUGUST 4, 2022

For years, the 47-year-old health care consultant had treated her high blood sugar with metformin. But to avoid a lifetime of medication, she knew she’d need to lose weight. She’d tried fad diets, Weight Watchers, Nutrisystem, and had even considered surgery when the results didn’t stick.

FDA Approval 119

FDA Approval Drugs Research 119

Rethinking Clinical Trials

MARCH 6, 2024

Schell Professor of Management and Applied Economics MIT Sloan School of Management Slides Keywords Food-as-Medicine, Randomized Clinical Trial, Diabetes Key Points Diabetes is common and costly. Food-as-Medicine observational studies have had a large correlation with improved health. 9% of the U.S.

Clinical Trials 141

Clinical Trials Clinical Trials Medicine Trials 141

Pharmaceutical Technology

MAY 26, 2023

The hands-off approach to diabetes management relies on Beta Bionic’s dosing algorithm. It only requires the user’s weight and CGM target values. CGM has become increasingly popular as technological advancements continue to facilitate easier health management.

Insulin 147

Insulin Manufacturing Pharmacy Marketing 147

Rethinking Clinical Trials

JULY 11, 2023

The NIH Collaboratory is excited to announce the addition of LE8 Bot + BackUp (or Using Artificially Intelligent Text Messaging Technology to Improve American Heart Association's Life's Essential 8 Health Behaviors) to its portfolio of innovative Demonstration Projects.

Trials 100

Trials Clinical Trials Clinical Trials Medicine 100

Pharmaceutical Technology

MAY 16, 2023

It will benefit from Omega’s newly opened injectable manufacturing facility, which has received clearances from Health Canada and the US Food and Drug Administration, as well as from Juno’s commercial network and product development pipeline.

Cosmetics 130

Cosmetics Allergies Manufacturing Production 130

World of DTC Marketing

JUNE 1, 2022

Five of America’s largest health insurers reported more than $11bn in profits in the second quarter – a decline from the same period last year when the Covid-19 pandemic helped drive sky-high profits yet they are having more of a say on patients’ treatments even when HCPs disagree.

Doctors 225

Doctors Doctor Nurses Drugs 225

World of DTC Marketing

JUNE 5, 2021

Research published by the World Health Organization found that a rise in fast food sales correlated to a rise in body mass index, and Americans are notorious for their fast-food consumption ? Add this to the higher amount of calories we are packing in, and we get a perfect recipe for weight gain. Obesity and Cancer.

Medicine 193

Medicine Gene Genetics Research 193

Drug Discovery World

NOVEMBER 15, 2023

The US Food and Drug Administration has approved Zepbound (tirzepatide) injection for chronic weight management alongside a reduced calorie diet and increased physical activity. The drug has also been approved (as Mounjaro) for weight loss by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK.

Trials 52

Trials Hormones Medicine Drugs 52

XTalks

MAY 17, 2023

New World Health Organization (WHO) guidance advises against the use of sugar substitutes for weight loss purposes. While a mild reduction in body weight may occur in the short term, it is not sustainable over time. However, the WHO guidance clarified that their recommendation does not address the safety of consumption.

Trials 98

Trials Research Production Regulation 98

Medical Xpress

JANUARY 5, 2023

In recent years, intermittent fasting has become a popular habit—and has been credited with some health benefits, be it to manage excess weight, chronic illnesses or flagging energy levels. On top of kickstarting a new exercise regime, the new year is traditionally a period when many people reconsider their eating habits.

75

75

STAT News

MARCH 28, 2023

After teetering close to severe malnutrition, she returned to a healthy weight. But new change may once again place her family at risk of food insecurity and poor health. In medicine, we are taught to follow the evidence and use research-based solutions for health.

Research 98

Research Medicine 98

Medical Xpress

MARCH 23, 2023

She is prescribed steroids to manage a lung condition and heart failure and has gained a significant amount of weight as a result of using the drugs. She was referred to the Community Mental Health Team because she had returned to her GP, concerned about her low mood, anxiety and difficulty walking.

Research 68

Research Drugs 68

Medical Xpress

NOVEMBER 30, 2022

Over three quarters of acute NHS trusts in England (77%) do not have a child weight management service, despite being responsible for providing specialist services for the most severely obese, according to a study led by researchers at the University of Bristol and supported by the National Institute for Health and Care Research (NIHR).

Research 64

Research 64

Trialfacts

OCTOBER 25, 2022

Losing weight can be challenging and stressful for women of all ages. Black women, in particular, are more susceptible to factors associated with obesity and obesity-related diseases and tend to lose less weight when attempting weight loss. Participants may experience improvements in their weight and/or stress levels.

Research 52

Research 52

Medical Xpress

DECEMBER 21, 2022

This is the time of year we make big promises to ourselves: "I will lose weight, start exercising, eat healthier…." Even if your end goal is big, research shows that baby steps are more likely to lead to sustainable, manageable, long lasting behavior change that gets you the results you want.

Research 72

Research 72

pharmaphorum

OCTOBER 27, 2021

Bayer’s two-year-old digital health collaboration with One Drop has borne its first fruit, an artificial intelligence-powered software module for preventing cardiovascular disease (CVD). ” The post Bayer, One Drop launch AI tool for heart disease prevention appeared first on.

Production 122

Production Development 122

World of DTC Marketing

MARCH 11, 2022

Trust is a vital determinant of health behaviors and outcomes, but COVID-19 has dramatically influenced how the public makes healthcare decisions, according to the February online survey of more than 10,000 people in 10 countries worldwide. However, the public is aware that they may need prescription drugs to manage chronic health conditions.

Pharma Companies 212

Pharma Companies Vaccination Vaccine Doctors 212

XTalks

MARCH 13, 2024

As the stars lined up on Hollywood Boulevard for the Oscars on Sunday evening, Eli Lilly took the stage with a TV ad that took shots at Hollywood’s latest weight loss frenzy — GLP-1 drugs. This has sparked criticism as those who need the medicines to manage their type 2 diabetes or obesity are facing challenges in accessing them.

Medicine 52

Medicine Cosmetics FDA Approval Drugs 52

Pharmaceutical Technology

APRIL 25, 2023

The German Federal Joint Committee (G-BA) has approved the eligibility of Imcivree for federal reimbursement by statutory health insurance for BBS in the country.

Genetics 130

Genetics FDA Approval Medicine Drugs 130

World of DTC Marketing

FEBRUARY 24, 2021

SUMMARY: In a recent study by The Harris Poll on behalf of TIME, the overwhelming majority of Americans (78%) admitted to delaying routine medical services and health care appointments due to the coronavirus pandemic. The health care industry should invest more in patient outreach, communication and education.

Pharma Production 200

Pharma Production Drugs Research Production 200

World of DTC Marketing

DECEMBER 22, 2020

In 2020, there should be over 592 million daily app downloads, and a survey by Gallup revealed that nearly half (45%) of Americans have at least tried digital health products such as fitness trackers or mobile health apps.Indeed, 1 in 5 (20%) have tried or are using both fitness trackers and apps. Weight monitors.

Doctors 230

Doctors Doctor Branding Development 230

XTalks

JANUARY 5, 2024

Eli Lilly launched LillyDirect this week, an online service that provides access to the company’s medicines, including its newly approved weight loss drug Zepbound (tirzepatide). In addition to these and Zepbound, Lilly’s medication for migraine management, Emgality (galcanezumab), is also available through the website.

Drugs 59

Drugs Pharmacy Cosmetics Insulin 59

pharmaphorum

AUGUST 8, 2022

A study of a mobile health app used to support patients hospitalised with heart failure has concluded that it provided a modest improvement in quality-of-life scores, as well as better clinical outcomes. It can be bewildering for heart failure patients to implement the advice of their doctors, says Pattern Health.

Doctors 145

Doctors Doctor Clinical Trials Clinical Trials 145

Trialfacts

MARCH 18, 2024

Designed to complement a healthy lifestyle, Retatrutide aims to assist adults in managing obesity, type 2 diabetes, and sleep apnoea. The study’s core focus is to assess the effectiveness and safety of this new anti-obesity medication, offering a beacon of possibility for those navigating these interconnected health challenges.

Insulin 52

Insulin Research Allergies Production 52

pharmaphorum

FEBRUARY 8, 2022

NICE has backed use of the Wegovy (semaglutide) for people with a body mass index (BMI) of 35 kg/m2 or more and at least one weight-related ailment – such as high blood pressure, high cholesterol or diabetes – as part of a weight management programme involving exercise and a reduce-calorie diet. kg/m2 lower.

Drugs 105

Drugs Contract Manufacturing Clinical Trials Clinical Trials 105

Pharmaceutical Technology

APRIL 13, 2023

Key opinion leaders (KOLs) interviewed by GlobalData highlighted the need for safer and more effective therapies with fewer side effects that would be suitable for the treatment of obesity, particularly for the management of weight loss following cessation of treatment.

Marketing 130

Marketing Clinical Trials Clinical Trials Development 130

XTalks

JANUARY 19, 2024

Novo Nordisk has re-started promotion of its weight-loss drug Wegovy (semaglutide) with a new TV advertisement after halting promotional materials for the drug last May. The promotional pause was made to manage the high demand for the weight loss injection.

Marketing 59

Marketing Life Science Drugs Branding 59

XTalks

JUNE 5, 2023

Ozempic was approved for the management of type 2 diabetes mellitus in adults in addition to a reduced-calorie diet and exercise. The recent surge in demand for Ozempic and Wegovy , driven largely by their perceived potential for weight loss touted on social media, has contributed to the semaglutide shortage.

FDA Approval 98

FDA Approval Containment Drugs Pharmacy 98

World of DTC Marketing

JULY 21, 2022

patients, and caregivers, are very active on social media and often reach out to each other to compare treatments and OTC products to help manage their M.S. DTC managers are often surprised by the results. I’m hoping that eventually, DTC managers will understand that they should not sponsor the evening news with the same T.V.

Marketing 266

Marketing Drugs Pharma Companies Doctors 266

World of DTC Marketing

AUGUST 13, 2021

While not all diabetes cases are linked to weight gain, overeating and eating too much is still the main cause of type 2 diabetes. Poor health habits cause not all obesity. And the world’s richest nation is losing this battle — even before COVID. 85 percent of people with diabetes are overweight.

Genetics 187

Genetics Drugs Medicine Development 187

XTalks

NOVEMBER 9, 2023

The FDA approved Zepbound for chronic weight management in adults with obesity. Both Ozempic and Mounjaro continue to enjoy stellar success as diabetes drugs and via off-label use for weight loss; the latter took off stupendously owing to endorsements (especially for Ozempic) on social media by celebrities and influencers.

FDA Approval 59

FDA Approval Manufacturing Drugs Pharmacy 59

XTalks

AUGUST 24, 2023

These new plans were thoughtfully introduced in response to the increasing demand from consumers managing specific medical conditions including celiac disease, type 2 diabetes, high blood pressure, polycystic ovarian syndrome (PCOS) and beyond. ” Related: Fresh Meal Maker FreshRealm Closes $200 Million Deal What is Food as Medicine?

Medicine 98

Medicine Marketing Drugs Research 98

pharmaphorum

AUGUST 24, 2021

Digital health startup Breathe Well-being has raised $5.5 million in first-round financing, which it will use to scale up its clinical tool that it says helps people “prevent, manage and reverse type 2 diabetes.”

Marketing 126

Marketing 126

Drug Discovery World

JULY 13, 2023

The drugs under review include Ozempic (semaglutide), Saxenda (liraglutide) and Wegovy (semaglutide), used for weight loss and for treating type 2 diabetes. Ozempic is authorised for the treatment of adults with insufficiently controlled type 2 diabetes as an adjunct to diet and exercise but has been used off-label for weight loss.

Drugs 52

Drugs Medicine Production 52

pharmaphorum

DECEMBER 10, 2021

US remote healthcare specialist ChronWell has raised $6 million from investors that will be used to accelerate the rollout of its patient management programmes for people with liver and gastrointestinal diseases. ModifyHealth’s meal plans help patients lose weight, the first line of treatment of NAFLD and NASH.

Development 75

Development 75